The Food and Drug Administration has updated its COVID-19 diagnostic testing FAQs, a reference for clinical laboratories, commercial manufacturers, and Food and Drug Administration staff. The document now lists the clinical laboratories that are offering testing under FDA's Policy for Diagnostic Tests for Coronavirus Disease-2019; states that have chosen to authorize laboratories to develop and perform COVID-19 tests; commercial manufacturers that are distributing test kits and the serology tests being offered. Among other information, it also offers alternatives for certain items that are in short supply but which are needed for collecting patient samples for testing for COVID-19 infection, such as alternative swabs and transport media

Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…